Trial Profile
Clinical trial of methoxy polyethylene glycol-epoetin beta (MIRCERA) for renal anemia with chronic heart failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2020
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 11 Jan 2020 Status changed from active, no longer recruiting to completed.
- 09 Jan 2020 Planned number of patients changed from 60 to 50.
- 19 Dec 2018 Planned number of patients changed from 40 to 60.